Product Number |
OACA02517 |
Product Page |
www.avivasysbio.com/aadac-antibody-oaca02517.html |
Name |
AADAC Antibody (OACA02517) |
Isotype |
IgG |
Conjugation |
Unconjugated |
NCBI Gene Id |
13 |
Host |
Rabbit |
Clonality |
Polyclonal |
Gene Full Name |
arylacetamide deacetylase |
Alias Symbols |
arylacetamide deacetylase;arylacetamide deacetylase (esterase);CES5A1;DAC. |
Product Format |
Liquid |
Description of Target |
Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity. |
Reconstitution and Storage |
-20°C or -80°C |
Datasheets/Manuals |
Printable datasheet for AADAC Antibody (OACA02517) (OACA02517) |
Immunogen |
Recombinant Human Arylacetamide deacetylase protein (24-399AA) |
Formulation |
50% Glycerol, 0.01M PBS, PH 7.4 |
Uniprot ID |
P22760 |
Protein Name |
Arylacetamide deacetylase |
Protein Accession # |
NP_001077 |
Purification |
Protein G Purified |
Nucleotide Accession # |
NM_001086 |
Preservative |
0.03% Proclin 300 |
Gene Symbol |
AADAC |
Predicted Species Reactivity |
Human |
Application |
Enzyme-linked immunosorbent assay|Immunohistochemistry |
Image 1 | Human prostate cancer
| Immunohistochemistry of paraffin-embedded human prostate cancer at dilution of 1:100 |
|
|